In the LinkedOmics dataset, the high expression of IGF2BP1, IGF2BP2, and IGF2BP3 was significantly associated with the poor overall survival of pancreatic cancer patients (Fig. 3a). This evidence concerns the gene IGF2BP1 and familial pancreatic carcinoma.